Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Shares Cross Below 200-Day Moving Average – Should You Sell?

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $6.85 and traded as low as $6.18. Neuberger Berman High Yield Strategies Fund shares last traded at $6.21, with a volume of 112,312 shares.

Neuberger Berman High Yield Strategies Fund Stock Performance

The business has a 50 day simple moving average of $6.29 and a 200-day simple moving average of $6.85.

Neuberger Berman High Yield Strategies Fund Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, July 31st. Stockholders of record on Wednesday, July 15th will be issued a $0.0905 dividend. The ex-dividend date is Wednesday, July 15th. This represents a c) annualized dividend and a dividend yield of 17.5%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Mercer Global Advisors Inc. ADV acquired a new stake in Neuberger Berman High Yield Strategies Fund in the 3rd quarter valued at about $80,000. Integrity Advisory Solutions LLC acquired a new position in shares of Neuberger Berman High Yield Strategies Fund in the 4th quarter worth approximately $81,000. XTX Topco Ltd bought a new stake in shares of Neuberger Berman High Yield Strategies Fund in the 2nd quarter worth approximately $113,000. CoreCap Advisors LLC acquired a new stake in Neuberger Berman High Yield Strategies Fund during the second quarter valued at approximately $119,000. Finally, Kestra Advisory Services LLC lifted its stake in Neuberger Berman High Yield Strategies Fund by 18.0% during the fourth quarter. Kestra Advisory Services LLC now owns 18,728 shares of the investment management company’s stock valued at $139,000 after purchasing an additional 2,857 shares during the last quarter.

Neuberger Berman High Yield Strategies Fund Company Profile

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.